Last reviewed · How we verify

NCT03958929

Impact of an Educational Video on Satisfaction After Glaucoma Surgery

Suspended NA Last updated 12 April 2023
What this trial tests

NA trial testing Educational Video in Glaucoma in 264 participants. Suspended.

Timeline
10 October 2023
Primary endpoint
10 January 2024
30 January 2024

Quick facts

Lead sponsorSun Yat-sen University
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment264
Start date10 October 2023
Primary completion10 January 2024
Estimated completion30 January 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sun Yat-sen University

Who can join

18 and older, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overall Objective: This study will assess whether an educational video is effective in increasing patient satisfaction with glaucoma surgery. 1. Investigate the impact of educational interventions on glaucoma patients' surgical satisfaction. 2. Investigate the post-operative satisfaction of rural glaucoma patients in county hospitals 3. Investigate the difference in postoperative satisfaction between urban and rural glaucoma patients in urban hospitals 4. Investigate other factors that influence postoperative glaucoma satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Educational Video

Trials testing the same drug.

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

Other Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing